Výsledky vyhledávání

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Autor: Öcal, Osman, Schinner, Regina, Schütte, Kerstin, de Toni, Enrico N., Loewe, Christian, van Delden, Otto, Vandecaveye, Vincent, Gebauer, Bernhard, Zech, Christoph J., Sengel, Christian, Bargellini, Irene, Gasbarrini, Antonio, Sangro, Bruno, Pech, Maciej, Malfertheiner, Peter, Ricke, Jens, Seidensticker, Max, Kettner, E., Amthauer, H., Cwikla, J., Walecki, J., Klümpen, H., Schott, E., Kolligs, F., Rosmorduc, O., Menu, Y., Leroy, V., Mayerle, J., Trumm, C., Bartenstein, P., Reiser, M., Berg, T., Moche, M., Bilbao, I., Gossner, L., Reimer, P., Popovic, P., Stabuc, B., Piasecki, P., Podgajny, Z., Sacco, R., Peck-Radosavljevic, M., Lammer, J., Maleux, G., Verslype, C., Rosenberg, C., Nitsche, D., Waldenberger, P., Vergniol, J., Cassinotto, C., Yalcin, S., Peynircioglu, B., Zavaglia, C., Rampoldi, A., Tran, A., Chevallier, P., Anty, R., Trautwein, C., Kuhl, C., Grazioli, L., Vogl, T., Trojan, J., Bartolozzi, C., Iezzi, R., Bronowicki, J. P., Palmer, D., Evans, J., Sharma, R., Weir, G., Hubner, R., Basu, B., Ross, P.

Publikováno v: Cancer Imaging, Vol 22, Iss 1, Pp 1-13 (2022)
Cancer imaging, 22(1):1. BioMed Central Ltd.
Öcal, O, Schinner, R, Schütte, K, de Toni, E N, Loewe, C, van Delden, O, Vandecaveye, V, Gebauer, B, Zech, C J, Sengel, C, Bargellini, I, Gasbarrini, A, Sangro, B, Pech, M, Malfertheiner, P, Ricke, J, Seidensticker, M, SORAMIC study group, Kettner, E, Amthauer, H, Cwikla, J, Walecki, J, Klümpen, H, Schott, E, Kolligs, F, Rosmorduc, O, Menu, Y, Leroy, V, Mayerle, J, Trumm, C, Bartenstein, P, Reiser, M, Berg, T, Moche, M, Bilbao, I, Gossner, L, Reimer, P, Popovic, P, Stabuc, B, Piasecki, P, Podgajny, Z, Sacco, R, Peck-Radosavljevic, M, Lammer, J, Maleux, G, Verslype, C, Rosenberg, C, Nitsche, D, Waldenberger, P, Vergniol, J, Cassinotto, C, Yalcin, S, Peynircioglu, B, Zavaglia, C, Rampoldi, A, Tran, A, Chevallier, P, Anty, R, Trautwein, C, Kuhl, C, Grazioli, L, Vogl, T, Trojan, J, Bartolozzi, C, Iezzi, R, Bronowicki, J P, Palmer, D, Evans, J, Sharma, R, Weir, G, Hubner, R, Basu, B & Ross, P 2022, ' Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib ', Cancer imaging, vol. 22, no. 1, 1 . https://doi.org/10.1186/s40644-021-00439-x
Cancer Imaging
Cancer imaging 22, 1 (2022). doi:10.1186/s40644-021-00439-x
Cancer imaging, 22(1):1. e-med

Cancer imaging 22, 1 (2022). doi:10.1186/s40644-021-00439-x
Published by BioMed Central, London

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4729d698b2dfd43c9c1a684f537d6364

Zobrazit plný text záznamu

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe

Autor: Lamarca, A., Morfouace, M., Tejpar, S., Oliveira, J., Capela, A., Penel, N., Gennigens, C., Brasiuniene, B., Peron, J., Stevovic, A., Blay, J.-Y., Klümpen, H.-J.

Publikováno v: Lamarca, A, Morfouace, M, Tejpar, S, Oliveira, J, Capela, A, Penel, N, Gennigens, C, Brasiuniene, B, Peron, J, Stevovic, A, Blay, J Y & Klümpen, H J 2022, ' Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843) : too few patients with matched treatment in Europe ', Annals of Oncology, vol. 33, no. 11, pp. 1200-1202 . https://doi.org/10.1016/j.annonc.2022.07.006
Annals of oncology, 33(11), 1200-1202. Oxford University Press
Annals of Oncology, 33(11), 1200-1202. Oxford University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::824248bc8cba036c47141486c1d2c9c5
https://pubmed.ncbi.nlm.nih.gov/35926814

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states

Publikováno v: ESMO open, 6(4):100174. Elsevier BV
ESMO Open
ESMO Open, European Society for Medical Oncology, 2021, 6 (4), pp.100174. ⟨10.1016/j.esmoop.2021.100174⟩
Blay, J Y, Casali, P, Bouvier, C, Dehais, C, Galloway, I, Gietema, J, Halámková, J, Hindi, N, Idbaih, A, Kinloch, E, Klümpen, H J, Kolarova, T, Kopeckova, K, Lovey, J, Magalhaes, M, Oselin, K, Piperno-Neumann, S, Ravnsbaek, A, Rogasik, M, Safwat, A, Scheipl, S, Seckl, M, Taylor, J, Temnyk, M, Trama, A, Urbonas, M, Wartenberg, M & Weinman, A 2021, ' European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states : a position paper of the ERN EURACAN ', ESMO Open, vol. 6, no. 4, 100174 . https://doi.org/10.1016/j.esmoop.2021.100174
ESMO Open, 6(4):100174. BMJ PUBLISHING GROUP

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e302f4c841400fbabdc29f138fcfdec5
https://doi.org/10.1016/j.esmoop.2021.100174

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání